You are here

  • Home
  • Archive
  • Volume 10, Issue 11
  • Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study

Article metrics

Article menu

Download PDFPDF

XML
Cardiovascular medicine
Original research
Evaluation of the incidence of bleeding in patients prescribed rivaroxaban for the treatment and prevention of deep vein thrombosis and pulmonary embolism in UK secondary care: an observational cohort study

 

Online download statistics by month:

Online download statistics by month: November 2020 to March 2023

AbstractFullPdf
Nov 2020462458112
Dec 2020716933
Jan 20211029728
Feb 2021949212
Mar 2021999618
Apr 2021949236
May 2021666220
Jun 2021494225
Jul 2021544716
Aug 2021302525
Sep 2021564624
Oct 2021332634
Nov 2021322324
Dec 2021382811
Jan 202243388
Feb 2022413912
Mar 202230259
Apr 2022262513
May 2022555017
Jun 2022433819
Jul 202235306
Aug 2022464043
Sep 2022313218
Oct 2022464020
Nov 2022242126
Dec 2022383412
Jan 2023453719
Feb 202328304
Mar 202321214
Total18321703648